德国拜耳利伐沙班效果到底好不好

As a new oral anticoagulant drug, its efficacy in preventing deep vein thrombosis in the lower extremities after hip replacement has been confirmed by many scholars. Foreign literature points out that extending the treatment course to 35 days can more significantly reduce the incidence of deep vein thrombosis.

A total of 106 patients who underwent primary unilateral hip replacement were selected and randomly divided into the rivaroxaban group and the low molecular weight heparin group. Both groups were administered 6 hours after replacement. The rivaroxaban group was administered 10 mg/d for a 5-week course of treatment; the low-molecular-weight heparin group was administered 4100 U/d for a 2-week course of treatment.

Results and conclusion: In the rivaroxaban group, no deep vein thrombosis occurred and no symptoms of deep vein thrombosis were found in the post-replacement review and follow-up of unilateral hip replacement patients. In the low molecular weight heparin group, 7 cases (13%) of patients with unilateral hip replacement were found to have deep vein thrombosis. The difference in the incidence of deep vein thrombosis between the two groups was significant (P<0.05). There was no significant difference in venous blood hemoglobin levels, platelet levels, coagulation function, post-replacement drainage volume and subcutaneous ecchymosis area between the two groups of unilateral hip replacement patients before and after replacement (P0.05). It is suggested that the application of rivaroxaban during the foot treatment after hip replacement has clear efficacy in preventing deep vein thrombosis, and the application of rivaroxaban during the foot treatment has reliable safety.

Bayer Group, a German pharmaceutical company, is one of the well-known Fortune 500 companies. Business scope includes medicine, diagnostic equipment, crop protection products, plastics and fibers, etc. According to Medical Companion Travel, there are currently two specifications of Bayer in Germany on sale, one specification is 20mg*28 tablets, and the other is 15mg*28 tablets. The two specifications of rivaroxaban are priced at 350$. Due to exchange rate fluctuations, the price is not fixed. If you want to buy rivaroxaban but do not want to go abroad, you can contact Medical Companion Travel to help you purchase rivaroxaban.